CJC1295 with DAC CAS：863288-34-0

CJC 1295 with dac (synonym CJC1295/DAC, changed kind (GRF 1-29) with drug affinity complex) belongs to category of tetrasubtituted amide endocrines and contains thirty amino acids; conjointly it is represented as analog of GH emotional hormone. Its formula is C165H269N47O46 and its molecular mass is 3647.28.

 

CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a releasing hormone (GHRH) analog.One of the advantages of CJC-1295 over traditional GHRH is its ability to bioconjugate with serum albumin, thus increasing its half-life and therapeutic window. It accomplishes this by using protecting groups around the amino acids of GHRH typically susceptible to enzymatic degradation

 

The clinical research was ultimately successful for most research subjects. Ghrelin, released from the gut, which circulates and acts as a hunger hormone, has synergistic activity in the body with GHRH and also suppresses somatostatin to make way for the GHRH pulse.

 

Application

 

CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human.

 

What are the cjc-1295 side effects?

 

CJC-1295 side effects are related to its stimulation of the pituitary gland. First, a surge of growth hormone (GH) will occur, sometimes causing vasodilation which is felt as a headrush or euphoria that lasts 30 minutes to 2 hours post injection. Mild irritation such as itching, redness, and pain is frequently noticed at the injection site and is not severe in most cases. At the cellular level, CJC-1295 raises HGH, and research shows subjects have increased fat metabolism, increased muscular mass and strength, and improved skin tone and muscular definition. Diet and exercise in conjunction with CJC-1295 will enhance effects.

 

CJC-1295 injection instructions

 

CJC-1925 is a sterile, non-pyrogenic, white lyophilized powder intended for subcutaneous or intramuscular injection, after reconstitution with sterile Water for Injection. CJC-1295 can be injected subcutaneously with an insulin syringe. Dose per injection: 2mg. Injections per vial: 1 x 2mg dosages Amount to Inject: If you have used 0.5ml of water for mixing then a 2mg dosage = 0.50ml (or 50 units on Insulin Syringe). If you have used 1ml of water then a 2mg dosage = 1ml (or 100 units). Sample Injection Frequency: 2mg injected once per week (due to its long half-life)

 

What are some Sample Injection Amounts?

 

CJC-1295 DAC 600mcg taken once per week, at any time of day. GHRP-2, GHRP-6 or Ipamorelin - Example 1- Night Time Injection (GHRP can cause drowsiness, and improve sleep). Empty stomach (i.e. 2-3 hours since your last meal). Inject GHRP peptide; go straight to bed. Example 2- Morning injection. Inject GHRP product first thing in the morning at 100mcg. Wait at least 20 minutes before consuming food or beverages (including coffee/tea).

CJC-1295 Doses

Modified GRF 1-29(cjc1295 w/o DAC):

Dose per injection: 100mcg

Injections per vial: 20 x 100mcg dosages

Amount to Inject: If you have used 1ml of water for mixing then a 100mcg dosage = 0.05ml (or 5 units on Insulin Syringe). If you have used 2ml of water for mixing then 100mcg = 0.10ml (or 10 units) and if you have used 3ml of water for mixing, then 100mcg = 0.15ml (or 15 units).

Injection Frequency:

100mcg injected 1-3 times per day, preferably together with a GHRP Peptide at 100-200mcg.

CJC-1295 DAC:

600mcg taken once per week, at any time of day.

Modified GRF 1-29 Injection Frequency:

100mcg injected 1-3 times per day, preferably together with a GHRP Peptide at 100-200mcg.